Cas:109113-97-5 6-chloro-2-(trifluoromethyl)imidazo[1,2-b]pyridazine manufacturer & supplier

We serve Chemical Name:6-chloro-2-(trifluoromethyl)imidazo[1,2-b]pyridazine CAS:109113-97-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

6-chloro-2-(trifluoromethyl)imidazo[1,2-b]pyridazine

Chemical Name:6-chloro-2-(trifluoromethyl)imidazo[1,2-b]pyridazine
CAS.NO:109113-97-5
Synonyms:6-chloro-2-trifluoromethylimidazo<1,2-b>pyridazine
Molecular Formula:C7H3ClF3N3
Molecular Weight:221.56700
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.68g/cm3
Index of Refraction:1.59
PSA:30.19000
Exact Mass:220.99700
LogP:2.40150

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 6-chloro-2-trifluoromethylimidazo&lt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,pyridazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2-b&gt Use and application,pyridazine technical grade,usp/ep/jp grade.


Related News: Earlier this year, the US Food and Drug Administration approved Verquvo to reduce the risk of cardiovascular death and heart failure hospitalisation, following a hospitalisation for heart failure or need for outpatients intravenous (IV) diuretics in adults with symptomatic chronic heart failure and ejection fraction less than 45%. 3,7-Diazabicyclo[3.3.1]nonane, 3-(butylsulfonyl)- manufacturers While BetterUp’s offering is already available in 46 languages and more than 90 countries, this official entrance into Europe will further solidify the company’s stature as the most comprehensive and personalized enterprise employee experience in the world. 5,8,14-Eicosatrienoic acid, 11-hydroxy-12-nitro-, (5Z,8Z,14Z)- suppliers In the trial, 362 eligible patients were randomised (1:1) and received a fixed-dose intravenous infusion of 300mg anifrolumab or placebo every four weeks. 4-[2-(2-Benzyloxymethoxy-3,5-dimethyl-phenyl)-1,2-dihydroxy-ethyl]-1-benzyloxymethyl-piperidine-2,6-dione vendor & factory.